Close
Nordic 9Nordic 9

Nuclide Therapeutics (private company)

United Kingdom nuclidetx.com
See something wrong or missing? Let us know
Offices:London
Industry:BiotechHealth servicesPharma
Business model:B2B

Nuclide Therapeutics is a British biotech startup spun off King’s College London and focused on developing targeted radiopharmaceuticals for therapy-resistant cancers,

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 6.72M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Nuclide Therapeutics

Name Criteria
Sweden Gradientech
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Denmark Octarine Bio
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France PEP-Therapy
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Sweden Intrance Medical Systems
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Sweden Atley Solutions
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Sweden Oncorena
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Netherlands InnoSIGN
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom CardiaTec Biosciences
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Poland Intelliseq
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France Lys Therapeutics
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Top